Epidemiological and molecular aspects of rifampicin-resistant Staphylococcus aureus isolated from wounds, blood and respiratory samples

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 5, 2011, Pages 997-1000

  Villar, María ^a   Marimón, José M ^a,b   García Arenzana, José M ^a   de la Campa, Adela G ^b,c   Ferrándiz, María J ^b,c   Pérez Trallero, Emilio ^a,b,d  

^a HOSPITAL DONOSTIA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Biofilms; Multilocus sequence types; Respiratory infections; rpoB

Indexed keywords

GLYCINE; RIFAMPICIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; BLOOD SAMPLING; CONTROLLED STUDY; GENE MUTATION; GENE SEQUENCE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR BIOLOGY; NONHUMAN; RESPIRATORY TRACT INFECTION; RIFAMPICIN RESISTANT STAPHYLOCOCCUS AUREUS; SPAIN; STAPHYLOCOCCUS AUREUS; WOUND;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL TYPING TECHNIQUES; CHILD; CLONING, MOLECULAR; DNA, BACTERIAL; DNA-DIRECTED RNA POLYMERASES; DRUG RESISTANCE; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; GENETIC COMPLEMENTATION TEST; GENOTYPE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTILOCUS SEQUENCE TYPING; POLYMORPHISM, GENETIC; RESPIRATORY TRACT INFECTIONS; RIFAMPIN; SEQUENCE ANALYSIS, DNA; SPAIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; WOUND INFECTION; YOUNG ADULT;

EID: 79954612167     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr059     Document Type: Article

References (10)

1. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339: 520-32.
2. Campbell EA, Korzheva N, Mustaev A et al. Structural mechanism for rifampicin inhibition of bacterial RNA polymerase. Cell 2001; 104: 901-12.
3. Darley ES, MacGowan AP. Antibiotic treatment of Gram-positive bone and joint infections. J Antimicrob Chemother 2004; 53: 928-35.
4. Zheng Z, Stewart PS. Penetration of rifampin through Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother 2002; 46: 900-3.
5. Aubry-Damon H, Soussy CJ, Courvalin P. Characterization of mutations in the rpoB gene that confer rifampin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 1998; 42: 2590-4.
6. Wichelhaus TA, Schafer V, Brade V et al. Molecular characterization of rpoB mutations conferring cross-resistance to rifamycins on methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1999; 43: 2813-6.
7. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twentieth Informational Supplement M100-S20. CLSI, Wayne, PA, USA, 2010.
8. Enright MC, Day NP, Davies CE et al. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 2000; 38: 1008-15.
9. Perlroth J, Kuo M, Tan J et al. Adjunctive use of rifampin for the treatment of Staphylococcus aureus infections: a systematic review of the literature. Arch Intern Med 2008; 168: 805-19.
10. Vindel A, Cuevas O, Cercenado E et al. Methicillin-resistant Staphylococcus aureus in Spain: molecular epidemiology and utility of different typing methods. J Clin Microbiol 2009; 47: 1620-7.